Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner

BJU International

Volumn 101, Issue 2, 2008, Pages 181-185

  Singh, Anurag K ^a   Krieger, Axel ^b   Lattouf, Jean Baptiste ^a   Guion, Peter ^a   Grubb III, Robert L ^a   Albert, Paul S ^a   Metzger, Greg ^c   Ullman, Karen ^a   Smith, Sharon ^a   Fichtinger, Gabor ^b   Ocak, Iclal ^a   Choyke, Peter ^a   Ménard, Cynthia ^d   Coleman, Jonathan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Johns Hopkins University   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biopsy; Dynamic contrast enhancement; Image guided; PSA level; TRUS

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FAMILY HISTORY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; CONTRAST MEDIA; DIGITAL RECTAL EXAMINATION; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 37349062337     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07219.x     Document Type: Article

References (23)

1. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005 95 : 751 6
2. Zackrisson B, Aus G, Lilja H, Lodding P, Pihl CG, Hugosson J. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Eur Urol 2003 43 : 327 32
3. Fleshner NE, O'Sullivan M, Fair WR. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997 158 : 505 8
4. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001 166 : 86 91
5. Fleshner N, Klotz L. Role of 'saturation biopsy' in the detection of prostate cancer among difficult diagnostic cases. Urology 2002 60 : 93 7
6. Yuen JS, Thng CH, Tan PH et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004 171 : 1482 6
7. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T. initial results. Radiology 2005 234 : 576 81
8. Amsellem-Ouazana D, Younes P, Conquy S et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005 47 : 582 6
9. Perrotti M, Han KR, Epstein RE et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 1999 162 : 1314 7
10. Ikonen S, Kivisaari L, Tervahartiala P et al. imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001 42 : 348 54
11. Mullerad M, Hricak H, Kuroiwa K et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005 174 : 2158 63
12. Padhani AR, Gapinski CJ, Macvicar DA et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000 55 : 99 109
13. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005 53 : 249 55
14. Futterer JJ, Heijmink SW, Scheenen TW et al. Prostate cancer: local staging at 3-T endorectal MR imaging - early experience. Radiology 2006 238 : 184 91
15. Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology 1991 179 : 49 53
16. Krieger A, Susil RC, Menard C et al. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng 2005 52 : 306 13
17. Menard C, Susil RC, Choyke P et al. An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement. Mol Imaging 2005 4 : 63 6
18. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995 75 : 2545 51
19. Bono AV, Celato N, Cova V, Salvadore M, Chinetti S, Novario R. Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis 2002 5 : 123 7
20. Beyersdorff D, Taupitz M, Winkelmann B et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002 224 : 701 6
21. Anastasiadis AG, Lichy MP, Nagele U et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 2006 50 : 738 48
22. Lattouf JB, Grubb RL, Lee JM et al. Yield of MRI directed trans-rectal ultrasound biopsies of the prostate in patients at high risk of having prostate cancer. BJU Int 2007 in press
23. Futterer JJ, Heijmink SW, Scheenen TW et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006 241 : 449 58